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867Radiation Dose Reduction in the
Invasive Cardiovascular Laboratory
Implementing a Culture and Philosophy of Radiation Safety
Objectives This paper investigates the effects of sustained practice and x-ray system technical
changes on the radiation dose administered to adult patients during invasive cardiovascular proce-
dures.
Background It is desirable to reduce radiation dose associated with medical imaging to minimize
the risk of adverse radiation effects to both patients and staff. Several clinical practice and technical
changes to elevate radiation awareness and reduce patient radiation dose were implemented under
the guidance of a cardiovascular invasive labs radiation safety committee. Practice changes included:
intraprocedure radiation dose announcements; reporting of procedures for which the air-kerma ex-
ceeded 6,000 mGy, including procedure air-kerma in the clinical report; and establishing compulsory
radiation safety training for fellows. Technical changes included establishing standard x-ray imaging
protocols, increased use of x-ray beam spectral ﬁlters, reducing the detector target dose for ﬂuoros-
copy and acquisition imaging, and reducing the ﬂuoroscopy frame rate to 7.5 s1.
Methods Patient- and procedure-speciﬁc cumulative skin dose was calculated from air-kerma values
and evaluated retrospectively over a period of 3 years. Data were categorized to include all proce-
dures, percutaneous coronary interventions, coronary angiography, noncardiac vascular angiography
and interventions, and interventions to treat structural heart disease. Statistical analysis was based
on a comparison of the cumulative skin dose for procedures performed during the ﬁrst and last
quarters of the 3-year study period.
Results A total of 18,115 procedures were performed by 27 staff cardiologists and 65 fellows-in-
training. Considering all procedures, the mean cumulative skin dose decreased from 969 to 568
mGy (40% reduction) over 3 years.
Conclusions This work demonstrates that a philosophy of radiation safety, implemented through a
collection of sustained practice and x-ray system changes, can result in a signiﬁcant decrease in the
radiation dose administered to patients during invasive cardiovascular procedures. (J Am Coll
Cardiol Intv 2012;5:866–73) © 2012 by the American College of Cardiology FoundationAlthough the patient dose associated with invasive cardiovas-
cular procedures is below the level that is known to be
associated with elevated cancer risk, it is assumed that even low
levels of radiation have a proportionate risk and that dose
should be minimized as much as possible (1,2). This risk
applies to patients as well as laboratory personnel who are
exposed to scatter radiation. High radiation skin dose can lead
to skin injury. Risks of both deterministic skin effects and
stochastic cancer risk associated with cardiac catheterization
procedures should be reduced by minimizing radiation dose
(3,4). Patient radiation dose-reduction initiatives have been
reported for radiofrequency ablation procedures (5,6) and
invasive coronary artery procedures (7,8). The purpose of this
work is to examine the effects of a sustained patient radiation
dose-reduction initiative implemented in a large and diverse
invasive cardiovascular practice.Methods
Radiation safety. An important component of modern car-
diovascular imaging is education about and implementation of
processes and techniques to reduce radiation dose. This in-
cludes properly adjusting the x-ray system during the procedure
and minimizing the duration of x-ray beam activation. Tech-
nical aspects of the x-ray system can be changed to reduce dose,
specifically radiation dose rate. Almost without exception, and
assuming that x-ray geometry is properly set, reduced dose rate
is associated with decreased image quality due to the reduced
frame rate and/or per-frame x-ray quantum fluence. To reduce
patient radiation dose requires that the physician’s expectations
change from a desire for excellent image quality to a desire for
low radiation dose and acceptance of clinically adequate image
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868standing of the technical capabilities of modern digital x-ray
imaging systems, particularly the flexibility in pulse rate, dose
per pulse, and x-ray spectral filtration that they provide.
In 2008, our practice established a Cardiovascular Interven-
tional Labs Radiation Safety Committee to oversee all aspects
of patient and staff radiation safety. The committee is com-
posed of a medical physicist, a health physicist from the
institutional radiation safety committee, cardiovascular labora-
tory nurses, x-ray technologists, cardiovascular invasive special-
ists, anesthesiologists, and physicians specifically interested in
radiation safety.
Radiation awareness and education. Staff members were
nstructed to consider strategies for radiation management
efore each case (Table 1). Air-kerma at the reference point
Ka,r) (mGy) is a patient radiation burden metric that is
reported by modern interventional x-ray systems (10). Ka,r is
specified at a fixed point in space relative to the x-ray source (to
approximate patient skin location) and is cumulative for an
entire procedure. Early in 2008, we began to announce
intraprocedure air-kerma values in increments of 3,000 mGy,
with the expectation that further
strategies for radiation dose man-
agement be implemented at each
announcement. Consistent with
Minnesota state regulation, pro-
cedures with Ka,r of 6,000 mGy or
greater are reported to our institu-
tional radiation safety committee.
To ensure quick and appropriate
communication of such proce-
dures, the x-ray technologist, su-
pervisor, and performing physi-
cian initiate a hard copy form
containing summary information
about the procedure and radiation exposure. This form also
contains instructions for immediate and 30-day follow-up
communication with the patient by the physician. To further
elevate radiation awareness by catheterization laboratory staff
and referring clinicians, Ka,r was included in the final report for
each procedure as of December 2009. X-ray imaging and
radiation safety laboratory sessions (3 h), including a practical
examination, were added to compulsory fellows training in July
2010. Many radiation safety practices were routinely followed
Table 1. Practice and Technical Changes to Elevate Patient Radiation Dos
Practice Changes Date Initiated
(A) CV Invasive Labs Radiation Safety Committee June 2008
(B) 6,000 mGy internal reporting June 2008
(C) 3,000 mGy announcement June 2008
(D) Include air-kerma (mGy) in ﬁnal report December 2009
(E) Compulsory fellows training July 2010
Abbreviations
and Acronyms
BMI  body mass index
CA  coronary angiography
CSD  cumulative skin dose




SH  structural heart
Vas  vascularCV cardiovascular.before and during the study period. These practices include:
activating x-ray imaging only when clinically indicated; ensur-
ing maximum practical distance between the x-ray source and
patient; minimizing the air gap between the patient and x-ray
detector; use of fluoroscopy image store; and use of a clinically
appropriate x-ray field of view. Secondary collimation to reduce
the x-ray field of view was used occasionally.
X-ray system technical changes. Procedures were performed
sing 4 Philips Integris (Philips Medical Systems, Best, the
etherlands) and 4 Axiom Artis (Siemens Medical, Erlangen,
ermany) interventional x-ray systems. Before the June 2008
tart date of this retrospective study, the x-ray systems used in
ur laboratory were actively managed to ensure clinically
ufficient image quality and acceptably low radiation dose rates.
pecifically, vendor-provided default dose rates were lowered
or both fluoroscopy and acquisition imaging. Throughout the
eriod from June 2008 through May 2011, several additional
-ray system technical changes were implemented to further
educe radiation dose to patients (Table 1). When appropriate,
roposed changes were first investigated with phantoms to
valuate their effect on radiation dose rate and image quality.
ext, for evaluation, the changes were implemented either in a
ingle x-ray system or within a small group of physicians. If
eemed satisfactory after the evaluation period, the changes
ere implemented for all systems and physicians. X-ray system
echnical changes included: standardization of the x-ray imag-
ng protocols among similar systems; default fluoroscopy dose
ate mode changed from normal to low; reduced dose rate
detector target dose) for fluoroscopy; reduced detector target
ose for acquisition imaging; increased use of Cu x-ray beam
pectral filters for acquisition imaging (11); and reduced fluo-
oscopy frame rate from 15 frames/s to 7.5 frames/s. If required
or specific clinical tasks, the fluoroscopy image quality and
atient skin dose rate may be increased tableside by increasing
he frame rate and/or changing from low to normal or high
uoroscopy mode. Also, a higher dose rate, improved image
uality acquisition x-ray program is maintained and can be
elected anytime during a procedure.
Data analysis. All invasive studies performed on adult patients
ver a 36-month period starting June 2008 were considered.
tudies performed on patients who had not provided medical
ecord research consent were excluded. The procedure air-
erma as reported by the x-ray system was recorded to the
reness and Reduce Radiation Dose Rate
Technical Changes Date Initiated
(F) Standardized x-ray protocols April 2009
(G) Increased spectral ﬁltration for acquisition imaging June 2009
(H) Default ﬂuoroscopy program set to low November 2009
(I) Fluoroscopy frame rate reduced to 7.5 frames/s December 2009
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869patient record. Whereas Ka,r refers to the primary x-ray beam
energy at a point in space, radiation dose also accounts for the
dose contribution of x-ray photons scattered from within the
patient and incident on a specific point within the patient
tissue. As previously described, air-kerma values were multi-
plied by a measured air-kerma to skin dose conversion factor,
resulting in the cumulative skin dose (CSD) (mGy) (12). This
conversion from air-kerma to cumulative skin dose served to
correct discrepancies between the system reported and actual
air-kerma and normalize system-dependent differences in the
units used to report air-kerma.
Preliminary investigation demonstrated that the radiation
dose change could be characterized using a linear fit to the
CSD data as a function of time or by direct comparison of the
data from the first and last quarters. The latter method was
chosen to simplify the presentation. Binary variable compari-
sons were tested using Pearson chi-square test. Continuous
variables were tested with the rank sum test. The Armitage
trend test was used to test for a trend in the proportion of
procedures with radiation exposure over 6 Gy in years 1, 2, and
3. Additionally, t tests of the log of cumulative radiation dose were
conducted and mean differences and 95% confidence intervals for
the difference were back-transformed to estimate the percentage of
CSD reduction for the last compared to the first 3 months. Data
analysis was performed to include all patient procedures, as well
as 4 specific procedural subsets, including percutaneous coro-
nary intervention (PCI), coronary angiography (CA), noncar-
diac vascular (Vas) angiography and intervention, and inter-
ventions to treat structural heart (SH) disease. The PCI subset
excluded Vas and SH; CA excluded PCI, Vas, and SH; Vas
excluded PCI and SH; and SH excluded PCI and Vas. As
patient size descriptors, body mass index (BMI), and sex are
known to influence radiation dose (12,13), these parameters
were examined to ensure lack of patient selection bias.
Results
Patient population summary. Over the 3-year study period,
18,675 patient studies were performed and 18,115 (97%) were
included in the summary statistics. There were 536 (2.9%) studies
excluded due to lack of research consent and 24 (0.1%) excluded
due to incomplete data. The patient population included 11,583
Table 2. Statistical Summary of Patient Population
Mean Median 25th Percentile 75th Percentile
Age, men, yrs 64.2 65 56 74
Age, women, yrs 64.2 66 54 75
Weight, men, kg 93.1 90.7 80 103
Weight, women, kg 77.1 74.0 63 88
BMI, men, kg/m2 30.0 29.1 26.1 32.9
BMI, women, kg/m2 29.5 28.3 24.3 33.7
BMI body mass index.(63.9%) male patients and 6,532 (36.1%) female patients. Themedian age was 66 years, BMI 29.0 kg/m2, and weight 85 kg
Table 2). Compared with male patients, female patients had a
imilar age distribution; on average, they weighed 16 kg less, and
hey had a BMI that was 0.5 kg/m2 lower.
Vascular procedures (n  459) included angiography and
ntervention for the following arteries: renal (394); carotid (84);
nd lower extremities (516). Structural heart procedures (1,070)
ncluded valvuloplasty (222); atrial/ventricular septal defect closure
evice implant (78); patent foramen ovale closure device implant
224); transcutaneous valve implantation (42); left ventricular assist
evice implant (53); device implant to treat paravalvular prosthetic
egurgitation (105); intra-aortic balloon pump insertion (330);
hunt embolization (31); and septal alcohol ablation (43).
CSD data summary. During the 3-year study period, 27 staff
ardiologists and 65 fellows-in-training performed or assisted
ith procedures. Individual staff physicians each performed
etween 100 (0.6%) to 1,515 (8.4%) procedures. Fellows
articipated in 86% of all procedures, although the specific level
f fellow involvement in a procedure was not measured.
hillips Integris x-ray systems were used for 7,176 (40%)
rocedures and Siemens Axiom Artis systems were used for
0,939 (60%) procedures. The monthly calculated median and
nterquartile range of CSD is provided in Figures 1 to 5 for all
n  18,115), PCI (4,062), CA (9,877), SH (1,070), and Vas
459) procedures, respectively. Also indicated on these longi-
udinal charts are the dates of implementation of the radiation
ose-reduction initiatives. In Figures 1 to 5, the relatively large
nterquartile range reflects the variability in the patient- and
rocedure-specific CSD values.
Table 3 provides a comparison of patient variables (sex,
MI) and procedural parameters (contrast volume, fluoroscopy
ime, percentage of radial access) for all procedures and the 4
rocedural subgroups during the first and last quarter of the
Figure 1. CSD—All Procedures
Monthly median cumulative skin dose (CSD) for all procedures. A to J indi-
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870study period. Among all 5 procedural groups, the percentage of
male patients and patient BMI were unchanged between the
first and last quarters. The percentage of cases in which a trainee
ellow participated increased from 73.0% to 83.5%. Fluoroscopy
ime increased significantly for all (median increase: 0.8 min;
1.4%) and CA (1.1 min; 9.6%) procedures. The fraction of
rocedures performed using radial access increased for all (absolute
ncrease:22.2%; relative increase: 331%), PCI (25.6%; 323%),
nd CA (24.4%; 348%) procedures.
CSD values for the first and last quarters are shown in
able 4 and Figure 6. Considering all procedures, the mean
Figure 2. CSD—PCI Procedures
Monthly median cumulative skin dose (CSD) for percutaneous interven-
tional procedures. A to J indicate initiation date for radiation safety
changes described in Table 1. PCI  percutaneous coronary intervention.
Figure 3. CSD—CA Procedures
Monthly median cumulative skin dose (CSD) for coronary angiography (CA)
procedures. A to J indicate initiation date for radiation safety changes
described in Table 1.SD decreased by 40%. The CSD decrease for PCI was 41%,
or CA 37%, for SH 34%, and for Vas 53%. Table 4 also
rovides the contribution to CSD from acquisition and fluo-
oscopy imaging. Considering all procedures, mean ac-
uisition skin dose decreased by 46% and fluoroscopy skin
ose decreased by 33%. Considering physicians who per-
ormed at least 10 cases in each of the first and last quarters,
9 of 21 were associated with patient radiation dose reduc-
ion in the range 22% to 69%. The remaining 2
perators were associated with patient radiation dose in-
reases of 6% and 33%.
Figure 4. CSD—SH Procedures
Monthly median cumulative skin dose (CSD) for structural heart (SH) proce-
dures. A to J indicate initiation date for radiation safety changes described
in Table 1.
Figure 5. CSD—Vas Procedures
Monthly median cumulative skin dose (CSD) for vascular (Vas) angiographic
and interventional procedures. A to J indicate initiation date for radiation
safety changes described in Table 1.
eous co
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871Table 5 provides a summary of the number of procedures for
which CSD exceeded 6,000 mGy during the first and last years
of the study period. Considering all procedures, there was a
significant reduction from 0.33% to 0.13% of procedures for
which CSD exceeded 6,000 mGy.
Discussion
This study demonstrates a 40% decrease in the radiation dose
administered to patients over a 3-year period and attributes this
decrease to a culture and philosophy of radiation safety imple-
mented through a number of practice and technical changes.
This overall dose reduction resulted from a combination of
reduced acquisition skin dose (46%) and fluoroscopy skin dose
(33%). This reduction was accomplished in a clinical environ-
ment with several x-ray systems, 27 physician operators, and 65
fellows-in-training while performing a wide variety of cardio-





1st Last 1st Last
Patient variables
n 1,580 1,475 364 332
Male, % 62.5 63.0 0.77 69.0 69.6
BMI, kg/m2, mean 29.7 29.9 0.53 30.9 30.1
Procedural parameters
Fellow participation, % 73.0 83.5 103 91.5 99.7
Contrast volume, cc, median 80 75 0.16 170 160
Fluoroscopy time, min, median 7.2 8.0 0.04 16.6 15.7
Radial access, % 6.7 28.9 103 7.9 33.4
BMI body mass index; CA coronary angiography; CSD cumulative skin dose; PCI percutan
Table 4. Statistical Summary of CSD, Acquisition Skin Dose, and Fluorosco
Quarter
All PCI
1st Last p Value 1st Last p Va
CSD, mGy
Mean 969 586 103 1,900 1,123 10
Median 642 401 1,609 952
25th percentile 325 202 1,074 604
75th percentile 1,280 759 2,328 1,491
Acquisition skin dose, mGy
Mean 502 271 103 903 452 10
Median 383 203 752 394
25th percentile 182 57 478 202
75th percentile 684 383 1,202 606
Fluoroscopy skin dose, mGy
Mean 467 315 103 997 682 10
Median 217 159 788 512
25th percentile 84 60 395 274
75th percentile 545 363 1,332 946Abbreviations as in Table 3.vascular procedures. Because radiation scatter that results in
occupational dose is directly proportional to patient dose,
reductions in patient dose can be expected to have a comple-
mentary effect on radiation dose to staff.
The effect of individual practice and technical changes on
patient dose can be expected to vary. Examination of the CSD
reported in Table 4 and Figures 1 to 5 demonstrates that there
is a great deal of interpatient and interprocedure variability in
CSD. Considering all procedures, the 25th and 75th percentile
CSD are approximately one-half to twice the median value,
respectively. This variability tends to mask CSD changes and
requires long-term perspective of patient dose to assess trends.
That the absolute effect of individual changes could not be
determined is a limitation of this work.
CSD values were reported for procedures performed in our
laboratory in 1997 (14). From 1997 to 2010, the median CSD







p Value1st Last 1st Last 1st Last
897 775 77 97 34 28
6 62.8 63.1 0.89 49.4 55.7 0.41 52.9 64.3 0.37
77 29.9 30.4 0.12 28.1 28.0 0.98 28.1 29.0 0.52
3 65.1 76.9 103 82.4 96.4 103 96.1 100.0 103
27 57.5 55.0 0.035 30.0 90.0 0.18 87.5 100.0 1.00
8 4.7 5.8 103 17.1 14.7 0.44 14.6 14.9 0.94
3 7.2 31.5 103 1.9 1.4 0.84 0 7.7 0.10
ronary intervention; SH structural heart; Vas vascular.
in Dose for the First and Last Quarters of the 3-Year Study Period
CA SH Vas
1st Last p Value 1st Last p Value 1st Last p Value
712 451 103 1,208 800 0.002 983 459 0.014
557 361 831 467 652 415
355 238 308 157 359 260
886 559 1,353 976 1,060 610
440 257 103 365 246 0.17 434 315 0.34
371 213 164 135 293 260
236 121 16 3.2 139 93
561 337 711 376 646 477
271 195 103 844 559 103 549 144 103
166 131 494 239 305 111
76 61 210 83 156 52
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872in our lab has decreased by 70% for both PCI and CA
procedures. Similar to the current 3-year study period, this
reduction can be attributed to a combination of practice and
technical changes. Since 1997, major technical changes in
interventional angiography equipment that affect radiation
dose include: a change from continuous to pulsed fluoroscopy;
reduction in fluoroscopy frame rate from 30 frames/s to 7.5
frames/s; reduction in acquisition frame rate from 30 frames/s
to 15 frames/s; improved x-ray image detection and display
systems; and increased use of metallic x-ray beam spectral
filters for both fluoroscopy and acquisition imaging. Further,
our x-ray systems allow for service level customization of image
Figure 6. 3-Year Radiation Dose Reduction
Reduction in cumulative skin dose between the ﬁrst and last quarters of
the 3-year study period. QTR  quarter.
Table 5. Summary of Procedures for Which the CSD Exceeded 6,000 mGy
Year
All PCI
1 3 p Value 1 3 p Value 1
n 20 8 0.04 10 4 0.19 1
% 0.33 0.13 0.72 0.31 0.03Abbreviations as in Table 3.receptor target dose, thus providing the potential for systematic
dose reduction.
The specific radiation dose-reduction methods presented in
this work represent only a subset of the radiation safety
practices that must be implemented routinely. The principles
that contribute to good radiation safety practices are well
known, and the reader is encouraged to review some of the
excellent literature pertaining to this topic (3,10,15). Relatively
new to the practice of radiation safety is intraprocedure
announcement of radiation dose metrics and post-procedure
reporting of high-dose procedures. The National Council on
Radiation Protection and Measurements recommends intrap-
rocedure announcements of air-kerma to occur at 1,000 mGy
increments starting at 3,000 mGy and recommends that
specific post-procedure management practices be implemented
following procedures with substantial radiation dose level
values 5,000 mGy. The National Council on Radiation Pro-
ection and Measurements has similar recommendations based on
kin dose and air-kerma area product values. Similar to those
escribed here, intraprocedure dose announcements and post-
rocedure management are expected to elevate radiation aware-
ess and reduce the frequency of high-dose procedures.
The literature contains examples of both relatively reduced
16) and increased patient radiation dose associated with radial
ersus femoral artery access procedures (13,17–19). The cur-
ent study demonstrated that patient dose was reduced con-
urrently with increased utilization of radial access. This study
as not designed to analyze the effect of radial versus femoral
ccess, and no causal association can be made regarding this issue.
his is an important topic that deserves specific investigation.
The CSD, used as a measurement of radiation dose burden
o the patient, was calculated directly from the air-kerma
eported by the x-ray system. Strictly, air-kerma specifies the
-ray energy at a discrete point within the x-ray field but does
ot account for the influence of x-ray beam field size (area) on
he total irradiation incident on the patient. Another metric of
adiation burden reported by modern x-ray systems is the
roduct of the air-kerma (Gy) and x-ray field area (cm2). The
ir-kerma area product (Gycm2) and related dose area product
(Gycm2) have been used by several investigators to describe
radiation burden for adult cardiovascular procedures (7,9,20–26).
For the data presented here, it is straightforward to estimate
dose area product as the product of CSD and x-ray field area
at the interventional reference point. Given a typical x-ray field
g the First and Last Years of the 3-Year Study Period
CA SH Vas
p Value 1 3 p Value 1 3 p Value
0.23 3 3 0.71 1 0 0.23
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873area of 70 cm2, the estimated mean dose area product for PCI
and CA procedures performed during the last quarter was 79
Gycm2 and 32 Gycm2, respectively.
onclusions
Large reductions in radiation dose can be achieved and should
be implemented in the cardiac catheterization lab to minimize
the risk of adverse radiation effects for patients and staff.
Considering all invasive procedures performed on adult patients in
our lab, CSD was decreased by 40% over a period of 3 years.
Building on a philosophy of radiation safety, substantial patient
radiation-dose reduction can be achieved through organized and
sustained practice and x-ray system technical changes.
Reprint requests and correspondence: Dr. Kenneth A. Fetterly,
Mayo Clinic, 200 1st Street SW, Rochester, Minnesota 55905.
E-mail: fetterly.kenneth@mayo.edu.
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